US Patent Number
Methods are disclosed that suggest the use of lobeline and analogs thereof in treating individuals for drug dependence and withdrawal and for eating disorders.
University of Kentucky Research Foundation, Lexington, Ky.
Crooks, Peter A. and Dwoskin, Linda P., "Lobeline Compounds as a Treatment for Psychostimulant Abuse and Withdrawal, and for Eating Disorders" (1998). Pharmaceutical Sciences Faculty Patents. 95.